SCN5A Gene Ventricular Fibrillation Paroxysmal Familial Type 1 Genetic Test
At DNA Labs UAE, we offer the SCN5A Gene Ventricular Fibrillation Paroxysmal Familial Type 1 Genetic Test. This test is designed to analyze the SCN5A gene and identify any mutations that may be present.
Test Components and Price
The price for the SCN5A Gene Ventricular Fibrillation Paroxysmal Familial Type 1 Genetic Test is 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
Once the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the analysis of multiple genes simultaneously.
Test Type and Doctor
The SCN5A Gene Ventricular Fibrillation Paroxysmal Familial Type 1 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is conducted by a cardiologist in our Genetics department.
Pre Test Information
Prior to undergoing the SCN5A Gene Ventricular Fibrillation Paroxysmal Familial Type 1 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by this genetic disorder.
Test Details
The SCN5A gene is responsible for encoding a protein called sodium channel alpha subunit 5, which plays a crucial role in the normal functioning of cardiac muscle cells. Mutations in this gene can disrupt the protein’s function, leading to various heart rhythm abnormalities.
Ventricular fibrillation is a life-threatening heart rhythm disorder characterized by rapid, chaotic electrical activity in the ventricles. If left untreated, it can result in loss of consciousness, cardiac arrest, and sudden death.
Paroxysmal familial type 1 ventricular fibrillation refers to a specific subtype of ventricular fibrillation that has a genetic basis and runs in families. It is characterized by intermittent episodes of ventricular fibrillation that can be triggered by factors such as exercise or emotional stress.
NGS genetic testing, also known as Next-Generation Sequencing, is a technique used to analyze multiple genes simultaneously and identify genetic mutations associated with specific diseases or conditions. In the context of ventricular fibrillation, NGS genetic testing can be used to identify mutations in the SCN5A gene or other genes known to be associated with familial ventricular fibrillation.
By identifying the specific genetic mutation responsible for ventricular fibrillation in an individual or family, NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment planning. It can also help identify at-risk family members who may benefit from regular cardiac monitoring or preventive measures.
| Test Name | SCN5A Gene Ventricular fibrillation paroxysmal familial type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SCN5A Gene Ventricular fibrillation, paroxysmal familial type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN5A Gene Ventricular fibrillation, paroxysmal familial type 1 NGS Genetic DNA Test gene SCN5A |
| Test Details | The SCN5A gene is responsible for encoding a protein called sodium channel alpha subunit 5, which is involved in the normal functioning of cardiac muscle cells. Mutations in the SCN5A gene can disrupt the normal function of this protein, leading to various heart rhythm abnormalities. Ventricular fibrillation is a life-threatening heart rhythm disorder characterized by rapid, chaotic electrical activity in the ventricles (lower chambers of the heart). It can result in loss of consciousness, cardiac arrest, and sudden death if not treated promptly. Paroxysmal familial type 1 ventricular fibrillation refers to a specific subtype of ventricular fibrillation that has a genetic basis and runs in families. It is characterized by intermittent episodes of ventricular fibrillation that can be triggered by certain factors, such as exercise or emotional stress. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify genetic mutations associated with specific diseases or conditions. In the context of ventricular fibrillation, NGS genetic testing can be used to identify mutations in the SCN5A gene or other genes known to be associated with familial ventricular fibrillation. By identifying the specific genetic mutation responsible for ventricular fibrillation in an individual or family, NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment planning. It can also help identify at-risk family members who may benefit from regular cardiac monitoring or preventive measures. |
